Summary: Resvent CPAP devices, including the iBreeze 20A (APAP) and iBreeze 30STA (BiPAP), are available in the United States under a US Food and Drug Administration (FDA) Emergency Use Authorization granted in April 2020. These devices are designed to improve patient adherence … [Read more...]